These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension. Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477 [No Abstract] [Full Text] [Related]
9. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition. Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241 [TBL] [Abstract][Full Text] [Related]
10. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme. Weber MA; Drayer JI; Priest RT; Chen TC Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients. Mizuno K; Gotoh M; Matsui J; Fukuchi S Jpn Heart J; 1981 Nov; 22(6):903-13. PubMed ID: 7040724 [TBL] [Abstract][Full Text] [Related]
12. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102 [TBL] [Abstract][Full Text] [Related]
13. Captopril in the treatment of hypertension in predialytic end-stage renal disease. Delin K; Aurell M; Herlitz H Contrib Nephrol; 1984; 41():299-303. PubMed ID: 6441676 [No Abstract] [Full Text] [Related]
14. Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme. Vaughan ED; Carey RM; Ayers CR; Peach MJ J Clin Endocrinol Metab; 1979 May; 48(5):869-71. PubMed ID: 219011 [TBL] [Abstract][Full Text] [Related]
15. Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade. Brunner HR; Gavras H; Waeber B Clin Exp Hypertens (1978); 1980; 2(3-4):639-57. PubMed ID: 6253243 [TBL] [Abstract][Full Text] [Related]
16. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
17. Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients. Giudicelli JF; Chaignon M; Richer C; Giroux B; Guedon J Br J Clin Pharmacol; 1984 Nov; 18(5):749-58. PubMed ID: 6095887 [TBL] [Abstract][Full Text] [Related]
18. [Potentiation of the antihypertensive effect of captopril by diuretics (author's transl)]. Waeber B; Brunner HR; Turini GA; Curtet N; Keller I; Gavras H Ann Cardiol Angeiol (Paris); 1979; 28(1):9-11. PubMed ID: 219758 [No Abstract] [Full Text] [Related]
19. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]